Therapeutic efficacy and safety of plasmapheresis in elderly patients with neuromyelitis optica spectrum disorder: a single-center observational study
Background: Neuromyelitis optica spectrum disorder (NMOSD) is a devastating autoimmune disorder with cycles of escalating relapse. Rates of diagnosis in the elderly are increasing. Therapeutic decision-making is more challenging in elderly patients due to multiple comorbidities and high risk of drug...
Main Authors: | Weihe Zhang, Yujuan Jiao, Lei Cui, Yeqiong Zhang, Jinsong Jiao, Ming Jin, Wei Yuan, Yang You, Renbin Wang, Dantao Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-03-01
|
Series: | Therapeutic Advances in Neurological Disorders |
Online Access: | https://doi.org/10.1177/17562864231162420 |
Similar Items
-
Dose effects of mycophenolate mofetil in Chinese patients with neuromyelitis optica spectrum disorders: a case series study
by: Yujuan Jiao, et al.
Published: (2018-04-01) -
Successful treatment of rituximab-unresponsive elderly-onset neuromyelitis optica spectrum disorder and hypogammaglobulinemia with ofatumumab plus intravenous immunoglobulin therapy in a patient with mutant FCGR3A genotype: A case report
by: Weihe Zhang, et al.
Published: (2022-12-01) -
Role of plasmapheresis in neuromyelitis optica spectrum disorders
by: Pranathi B, et al.
Published: (2019-10-01) -
Role of low plasma volume treatment on clinical efficacy of plasmapheresis in neuromyelitis optica
by: Akshay Batra, et al.
Published: (2017-01-01) -
Plasmapheresis for Neuromyelitis Optica: A Review from the Transfusion Medicine Specialist’s Perspective
by: Akshay Batra, et al.
Published: (2018-08-01)